Dose prescription for stereotactic body radiotherapy: general and organ-specific consensus statement from the DEGRO/DGMP Working Group Stereotactic Radiotherapy and Radiosurgery

[1]  A. McWilliam,et al.  Stereotactic body radiotherapy for centrally located inoperable early-stage NSCLC: EORTC 22113-08113 LungTech phase II trial results. , 2024, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[2]  H. Bahig,et al.  Stereotactic Radiation for Ultra-Central Non-Small Cell Lung Cancer: A Safety and Efficacy Trial (SUNSET). , 2024, International journal of radiation oncology, biology, physics.

[3]  Jiangping Yang,et al.  Dosimetric comparison in sparing normal tissue dosage by using auto-SBRT planning in oligo liver tumors , 2023, Frontiers in oncology.

[4]  M. Sidhom,et al.  TROG 15.03/ANZUP International Multicenter Phase II Trial of Focal Ablative STereotactic RAdiotherapy for Cancers of the Kidney (FASTRACK II). , 2023, International journal of radiation oncology, biology, physics.

[5]  M. Scorsetti,et al.  Stereotactic body radiotherapy for hepatocellular carcinoma: meta-analysis and International Stereotactic Radiosurgery Society practice guidelines. , 2023, International journal of radiation oncology, biology, physics.

[6]  Y. Shioyama,et al.  Difference in target dose distributions between Acuros XB and collapsed cone convolution/superposition and the impact of the tumor locations in clinical cases of stereotactic ablative body radiotherapy for lung cancer , 2023, Journal of cancer research and therapeutics.

[7]  A. Bezjak,et al.  Radiotherapy for Lung Metastases: Conventional to Stereotactic Body Radiation Therapy. , 2023, Seminars in radiation oncology.

[8]  C. Hallemeier,et al.  Radiation of bilateral adrenal metastases is associated with a high risk of primary adrenal insufficiency , 2023, Clinical endocrinology.

[9]  R. van Hillegersberg,et al.  Definition, diagnosis and treatment of oligometastatic oesophagogastric cancer: A Delphi consensus study in Europe. , 2023, European journal of cancer.

[10]  A. Hounsell,et al.  Patient specific evaluation of breathing motion induced interplay effects. , 2022, Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics.

[11]  L. Dawson,et al.  Insights from IGRT Credentialing for the NRG Oncology RTOG 1112 Liver SBRT Trial. , 2022, Practical radiation oncology.

[12]  L. Dawson,et al.  NRG/RTOG 1112: Randomized Phase III Study of Sorafenib vs. Stereotactic Body Radiation Therapy (SBRT) Followed by Sorafenib in Hepatocellular Carcinoma (HCC) (NCT01730937) , 2022, International Journal of Radiation Oncology*Biology*Physics.

[13]  S. Lo,et al.  Stereotactic Body Radiotherapy for Renal Cell Carcinoma in Patients with Von Hippel–Lindau Disease—Results of a Prospective Trial , 2022, Cancers.

[14]  R. Sweeney,et al.  Stereotactic body radiotherapy of adrenal metastases—A dose‐finding study , 2022, International journal of cancer.

[15]  M. Ychou,et al.  Stereotactic MR-Guided Radiotherapy for Pancreatic Tumors: Dosimetric Benefit of Adaptation and First Clinical Results in a Prospective Registry Study , 2022, Frontiers in Oncology.

[16]  D. Eaton,et al.  UK 2022 Consensus on Normal Tissue Dose-Volume Constraints for Oligometastatic, Primary Lung and Hepatocellular Carcinoma Stereotactic Ablative Radiotherapy. , 2022, Clinical oncology (Royal College of Radiologists (Great Britain)).

[17]  R. Timmerman.  A Story of Hypofractionation and the Table on the Wall. , 2022, International journal of radiation oncology, biology, physics.

[18]  C. Bäumer,et al.  Planning benchmark study for SBRT of liver metastases: Results of the DEGRO/DGMP working group stereotactic radiotherapy and radiosurgery. , 2022, International journal of radiation oncology, biology, physics.

[19]  I. Poon,et al.  An analysis of a large multi-institutional database reveals important associations between treatment parameters and clinical outcomes for stereotactic body radiotherapy (SBRT) of oligometastatic colorectal cancer. , 2021, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[20]  S. Vinod,et al.  Single-Fraction vs Multifraction Stereotactic Ablative Body Radiotherapy for Pulmonary Oligometastases (SAFRON II): The Trans Tasman Radiation Oncology Group 13.01 Phase 2 Randomized Clinical Trial. , 2021, JAMA oncology.

[21]  R. Fietkau,et al.  12 × 6 Gy stereotactic radiotherapy for lung tumors. Is there a difference in response between lung metastases and primary bronchial carcinoma? , 2021, Strahlentherapie und Onkologie.

[22]  P. Winkler,et al.  Improving interinstitutional and intertechnology consistency of pulmonary SBRT by dose prescription to the mean internal target volume dose , 2021, Strahlentherapie und Onkologie.

[23]  M. Oldham,et al.  Report of AAPM Task Group 155: Megavoltage photon beam dosimetry in small fields and non-equilibrium conditions. , 2021, Medical physics.

[24]  I. Lax,et al.  The HILUS-trial - a prospective Nordic multi-center phase II study of ultra-central lung tumors treated with stereotactic body radiotherapy. , 2021, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[25]  Laurence E. Court,et al.  Development and dosimetric assessment of an automatic dental artifact classification tool to guide artifact management techniques in a fully automated treatment planning workflow , 2021, Comput. Medical Imaging Graph..

[26]  D. Followill,et al.  Report dose-to-medium in clinical trials where available; a consensus from the global Harmonisation group to maximize consistency. , 2021, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[27]  C. Kornhuber,et al.  Stereotactic or conformal radiotherapy for adrenal metastases: Patient characteristics and outcomes in a multicenter analysis , 2021, International journal of cancer.

[28]  J. Boda-Heggemann,et al.  In-field stereotactic body radiotherapy (SBRT) reirradiation for pulmonary malignancies as a multicentre analysis of the German Society of Radiation Oncology (DEGRO) , 2021, Scientific Reports.

[29]  K. Haustermans,et al.  ESTRO ACROP guidelines for target volume definition in pancreatic cancer. , 2020, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[30]  C. Cavedon,et al.  Hypofractionated Stereotactic Body Radiation Therapy With Simultaneous Integrated Boost and Simultaneous Integrated Protection in Pancreatic Ductal Adenocarcinoma. , 2020, Clinical oncology (Royal College of Radiologists (Great Britain)).

[31]  J. Debus,et al.  Definition and quality requirements for stereotactic radiotherapy: consensus statement from the DEGRO/DGMP Working Group Stereotactic Radiotherapy and Radiosurgery , 2020, Strahlentherapie und Onkologie.

[32]  R. Werner,et al.  Technological quality requirements for stereotactic radiotherapy , 2020, Strahlentherapie und Onkologie.

[33]  H. Eich,et al.  Correlating dose variables with local tumor control in stereotactic body radiotherapy for early stage non-small cell lung cancer: A modelling study on 1500 individual treatments. , 2020, International journal of radiation oncology, biology, physics.

[34]  T. B. Nyeng,et al.  Variation in current prescription practice of stereotactic body radiotherapy for peripherally located early stage non-small cell lung cancer: Recommendations for prescribing and recording according to the ACROP guideline and ICRU report 91. , 2019, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[35]  V. Bernard,et al.  Pancreas SBRT: Who, What, When, Where, and How…. , 2019, Practical radiation oncology.

[36]  F. Araki,et al.  Dependence of volume dose indices on dose calculation algorithms for VMAT-SBRT plans for peripheral lung tumor. , 2019, Medical dosimetry : official journal of the American Association of Medical Dosimetrists.

[37]  I. Kaplan,et al.  The Emerging Role of Stereotactic Ablative Radiotherapy for Primary Renal Cell Carcinoma: A Systematic Review and Meta-Analysis. , 2019, European urology focus.

[38]  Ming Chen,et al.  Choice of immobilization of stereotactic body radiotherapy in lung tumor patient by BMI , 2019, BMC Cancer.

[39]  O. Riesterer,et al.  Stereotactic body radiotherapy dose and its impact on local control and overall survival of patients for locally advanced intrahepatic and extrahepatic cholangiocarcinoma. , 2019, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[40]  Oliver Blanck,et al.  ICRU report 91 on prescribing, recording, and reporting of stereotactic treatments with small photon beams , 2019, Strahlentherapie und Onkologie.

[41]  J. Rydhög,et al.  Advanced dose calculation algorithms in lung cancer radiotherapy: Implications for SBRT and locally advanced disease in deep inspiration breath hold. , 2018, Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics.

[42]  A. Grosu,et al.  Repeated SBRT for in- and out-of-field recurrences in the liver , 2018, Strahlentherapie und Onkologie.

[43]  V. Khoo,et al.  TROG 15.03 phase II clinical trial of Focal Ablative STereotactic Radiosurgery for Cancers of the Kidney - FASTRACK II , 2018, BMC Cancer.

[44]  Liying Zhang,et al.  The safety and effectiveness of stereotactic body radiotherapy for central versus ultracentral lung tumors. , 2018, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[45]  A. Louie,et al.  SUNSET: Stereotactic Radiation for Ultracentral Non-Small-Cell Lung Cancer-A Safety and Efficacy Trial. , 2018, Clinical lung cancer.

[46]  L. Dawson,et al.  Baseline Albumin-Bilirubin (ALBI) Score in Western Patients With Hepatocellular Carcinoma Treated With Stereotactic Body Radiation Therapy (SBRT). , 2018, International journal of radiation oncology, biology, physics.

[47]  J. Sonke,et al.  Results of a multicentre dosimetry audit using a respiratory phantom within the EORTC LungTech trial. , 2018, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[48]  I. Kaplan,et al.  Pooled analysis of stereotactic ablative radiotherapy for primary renal cell carcinoma: A report from the International Radiosurgery Oncology Consortium for Kidney (IROCK) , 2018, Cancer.

[49]  A. Grosu,et al.  The role of albumin–bilirubin grade and inflammation-based index in patients with hepatocellular carcinoma treated with stereotactic body radiotherapy , 2018, Strahlentherapie und Onkologie.

[50]  E. Hubley,et al.  The influence of plan modulation on the interplay effect in VMAT liver SBRT treatments. , 2017, Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics.

[51]  H. Eich,et al.  Planning benchmark study for SBRT of early stage NSCLC , 2017, Strahlentherapie und Onkologie.

[52]  R. Semrau,et al.  Stereotactic body radiotherapy for oligo-metastatic liver disease - Influence of pre-treatment chemotherapy and histology on local tumor control. , 2017, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[53]  D. Baltas,et al.  Stereotactic body radiotherapy (SBRT) in recurrent or oligometastatic pancreatic cancer , 2017, Strahlentherapie und Onkologie.

[54]  T. Brunner,et al.  Stereotactic body radiotherapy for renal cell cancer and pancreatic cancer , 2016, Strahlentherapie und Onkologie.

[55]  D. Baltas,et al.  Simultaneous integrated protection , 2016, Strahlentherapie und Onkologie.

[56]  S. Eschrich,et al.  Radiosensitivity Differences Between Liver Metastases Based on Primary Histology Suggest Implications for Clinical Outcomes After Stereotactic Body Radiation Therapy. , 2016, International journal of radiation oncology, biology, physics.

[57]  S. Senan,et al.  Outcomes of Hypofractionated High‐Dose Radiotherapy in Poor‐Risk Patients with “Ultracentral” Non–Small Cell Lung Cancer , 2016, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[58]  Oliver Blanck,et al.  Local tumor control probability modeling of primary and secondary lung tumors in stereotactic body radiotherapy. , 2016, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[59]  H. Onishi,et al.  Consensus statement from the International Radiosurgery Oncology Consortium for Kidney for primary renal cell carcinoma. , 2016, Future oncology.

[60]  Jan-Jakob Sonke,et al.  Lungtech, a phase II EORTC trial of SBRT for centrally located lung tumours – a clinical physics perspective , 2016, Radiation Oncology.

[61]  J. Lehmann,et al.  National dosimetric audit network finds discrepancies in AAA lung inhomogeneity corrections. , 2015, Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics.

[62]  Albert C. Koong,et al.  Phase 2 Multi-institutional Trial Evaluating Gemcitabine and Stereotactic Body Radiotherapy for Patients With Locally Advanced Unresectable Pancreatic Adenocarcinoma , 2014, Cancer.

[63]  K. Herfarth,et al.  Stereotactic body radiotherapy for liver tumors , 2014, Strahlentherapie und Onkologie.

[64]  L. Dawson,et al.  Outcomes following definitive stereotactic body radiotherapy for patients with Child-Pugh B or C hepatocellular carcinoma. , 2014, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[65]  Matthias Guckenberger,et al.  Applicability of the linear-quadratic formalism for modeling local tumor control probability in high dose per fraction stereotactic body radiotherapy for early stage non-small cell lung cancer. , 2013, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[66]  O. Sauer,et al.  Definition of stereotactic body radiotherapy , 2013, Strahlentherapie und Onkologie.

[67]  J. Vandemeulebroucke,et al.  Is abdominal compression useful in lung stereotactic body radiation therapy? A 4DCT and dosimetric lobe-dependent study. , 2013, Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics.

[68]  David S Followill,et al.  Algorithms used in heterogeneous dose calculations show systematic differences as measured with the Radiological Physics Center's anthropomorphic thorax phantom used for RTOG credentialing. , 2012, International journal of radiation oncology, biology, physics.

[69]  M. Miften,et al.  Radiation-associated liver injury. , 2010, International journal of radiation oncology, biology, physics.

[70]  T. Desser,et al.  Gemcitabine chemotherapy and single-fraction stereotactic body radiotherapy for locally advanced pancreatic cancer. , 2008, International journal of radiation oncology, biology, physics.

[71]  Ross Berbeco,et al.  Management of the interplay effect when using dynamic MLC sequences to treat moving targets. , 2008, Medical physics.

[72]  Steve B. Jiang,et al.  The management of respiratory motion in radiation oncology report of AAPM Task Group 76a). , 2006, Medical physics.

[73]  R. Timmerman,et al.  Extracranial Stereotactic Radioablation Physical Principles , 2003, Acta oncologica.

[74]  H. Dralle,et al.  Critical size of residual adrenal tissue and recovery from impaired early postoperative adrenocortical function after subtotal bilateral adrenalectomy. , 2003, Surgery.

[75]  A. Khorana,et al.  Radiation Therapy for Pancreatic Cancer: Executive Summary of an ASTRO Clinical Practice Guideline. , 2019, Practical radiation oncology.

[76]  Daniel T Chang,et al.  Central liver toxicity after SBRT: An expanded analysis and predictive nomogram. , 2017, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[77]  A. Grosu,et al.  SBRT in pancreatic cancer: what is the therapeutic window? , 2015, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.